Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CRISPR Therapeutics AG | Chief Operating Officer | Common Shares | 7.09K | $398K | $56.09 | Jun 20, 2024 | The Julianne Bruno 2022 GRAT |
CRISPR Therapeutics AG | Chief Operating Officer | Common Shares | 6.75K | $378K | $56.09 | Jun 21, 2024 | Direct |
CRISPR Therapeutics AG | Chief Operating Officer | Stock Option (Right to Buy) | 18.3K | Oct 16, 2024 | Direct | ||
CRISPR Therapeutics AG | Chief Operating Officer | Restricted Stock Units | 0 | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRSP | CRISPR Therapeutics AG | Oct 16, 2024 | 1 | $0 | 4 | Oct 18, 2024 | Chief Operating Officer |
CRSP | CRISPR Therapeutics AG | Jun 20, 2024 | 3 | -$189K | 4 | Jun 24, 2024 | Chief Operating Officer |
CRSP | CRISPR Therapeutics AG | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Chief Operating Officer |
CRSP | CRISPR Therapeutics AG | May 23, 2024 | 0 | $0 | 3 | May 23, 2024 | Chief Operating Officer |